top of page
Search

What You Should Check in Your Private Health Insurance Medicine Coverage

  • Writer: Insight אינסייט פתרונות פיננסיים
    Insight אינסייט פתרונות פיננסיים
  • Jul 20, 2023
  • 1 min read

Updated: Jan 14, 2024




What You Should Check in Your Private Health Insurance Medicine Coverage

One of the cheapest yet most important coverages in private health insurance is the coverage for life-saving and life-prolonging Medicine that isn't in the healthcare basket, which has been updated quite a bit over the years.

From chemical drugs until 2007, with low coverage for up to 600K NIS only, to off-label experimental drugs and personalized drugs based on personal DNA after genomic testing (added after 02.2016), covering millions of shekels.

Today's medical technology can do amazing things, like zoning in on cancer cells and destroying only them, but this medicine is getting more and more expensive, as it is becoming more refined and advanced.

Insurance coverage from before 02.2016 doesn't update every two years like the newer policies. The newer policies are also updated once in a while, and it is recommended to check the added appendices and assess if they're worthwhile.

It is recommended to ensure (preferably with the help of an insurance agent) that your existing private health insurance policy includes the latest coverage for drugs that aren't included in the healthcare basket, as well as sufficient coverage for genomic testing which costs around 50K NIS.

 
 
 

Comments


Do you have a question

Are you interested in cutting the cost (but not the value) of your insurance portfolio?

Insight Financial Solutions

m@sght.co.il    |    054-445-5334
תמונת פרופיל לרשתות חברתיות-13.png
תמונת פרופיל לרשתות חברתיות-12.png
תמונת פרופיל לרשתות חברתיות-11.png
תמונת פרופיל לרשתות חברתיות-08.png
תמונת פרופיל לרשתות חברתיות-09.png
תמונת פרופיל לרשתות חברתיות-07.png
תמונת פרופיל לרשתות חברתיות-10.png

The said expression or any of its parts should not be construed as investment advice, pension or any recommendation. The foregoing does not constitute investment advice or marketing, pension, taxation, or a substitute for advice that takes into account the data and special needs of each person.

errors and omissions excepted

© Design:                                              - MEITAL YAKOV | Video shooting: Or Bolandian אור בולנדיאן | Photos and video: Mark Colton מארק קולטון

חומרים למיתוג-03.png
bottom of page